NSIV Newsletter – October 2018 Find out more about: NSIV Member Spotlight –Inovotion InBIA Soft Landings Designation – Update Welcome Erica Pratt, New Lab Manager Tom is our IRONMAN Events, News and Updates Read the newsletter in your browser or open it as a PDF.Read more
Blog
For patients dealing with anxiety, depression, phobia, and other behavioral illnesses, even going out to see a therapist face-to-face can be a real barrier to treatment. iHope Network recognizes this: multiple studies find no-show rates of 10-30% at a typical brick-and-mortar practice, while a recent check of iHope’s online appointments found only 28 no-shows outRead more
NSIV Newsletter – September 2018 Find out more about: Member Spotlight – iHope Network InBIA Soft Landing Designation Awarded New Faces at NSIV Other Highlights Events of Interest Read the newsletter in your browser or open it as a PDF.Read more
NSIV Newsletter – August 2018 NSIV is one of the leading cleantech and biotech incubators in Massachusetts. Learn more about: Member Spotlight – HepatoChem Summer Interns Present Accomplishments NSIV Companies Making News Other News of Interest Read the newsletter in your browser or open it as a PDF.Read more
HepatoChem was founded as a company for metabolite production, hence the name — “Hepato” refers to the liver, which is the organ responsible for most of metabolism. The company provides a sort “chemical liver” for biotech and pharma companies by processing drugs in the same way that they would be processed in the human body.Read more
Once again, interns working at NSIV impressed us with all they accomplished, both for their companies and personally. At the August InnoVentures U, our summer interns made formal presentations before a group of 30, explaining what kind of projects they were engaged in and the impact of their work. Great prep for being able toRead more
July 2018 Find out more about: Getting to Know CEO Chris Ilsley Member Spotlight – Glycologix Five Words – Our Companies Do What? Around the World with NSIV Read the newsletter in your browser or open it as a PDF.Read more
New NSIV CEO & President, Chris Ilsley (say “ills lee”) has been with us for just over a month. We briefly introduced him to you in last month’s newsletter, but now it’s time for a bit more in-depth look. To help us get acquainted, he recently sat down for a Q&A. Find out about hisRead more
June 2018 Find out more about: Welcome to New NSIV President & CEO Member Spotlight – Genomic Expression New Companies Join NSIV Summer Interns are Here! The World Cup Read the newsletter in your browser or open it as a PDF.Read more
Every year, $100 billion goes into standard cancer treatment, prescribed based on the cancer’s stage and tissue of origin. Patients receiving these treatments assume that they are being given the medicine they need, but the reality is inauspicious — every cancer is unique, and only 1 out of 4 standard treatments will actually prolong life.Read more